Table 1.
Distribution of demographic and cancer characteristics by hot flash reporting
| Hot flashes n(%) 674(78) |
No hot flashes n(%) 190(22) |
P-value | |
|---|---|---|---|
| Age in years Mean(SD) | 54(8) | 54(10) | 0.66 |
| Race/Ethnicity | 0.43 | ||
| Caucasian | 580(78) | 161(22) | |
| Hispanic | 38(83) | 8(17) | |
| Asian | 21(70) | 9(30) | |
| African American | 19(83) | 4(17) | |
| Other | 16(67) | 8(33) | |
| Stage of breast cancer | 0.81 | ||
| I | 253(78) | 70(22) | |
| II | 300(77) | 89(23) | |
| III | 121(80) | 31(20) | |
| Hormone receptor status | 0.07 | ||
| ER+/PR+ | 525(79) | 143(21) | |
| ER+/PR− | 88(73) | 32(27) | |
| ER−/PR+ | 27(96) | 1(4) | |
| ER−/PR− | 23(72) | 9(28) | |
| Unknown PR | 11(69) | 5(31) | |
| Adjuvant therapy | 0.22 | ||
| Chemotherapy + Tamoxifen | 427(79) | 111(21) | |
| Tamoxifen only | 247(76) | 79(24) | |
| Months on tamoxifen, Mean(SD) | 19(13) | 21(13) | 0.01 |
| Months since diagnosis, Mean(SD) | 23(12) | 26(13) | 0.01 |
| Recurrence of Cancer | 0.02 | ||
| None | 587(80) | 150(20) | |
| Local/Regional | 7(50) | 7(50) | |
| Contralateral | 8(62) | 5(38) | |
| Distant | 72(72) | 28(28) |